Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Oesophageal cancer, Secondary cancers
Closed
Pilot
This study is measuring circulating tumour DNA to find out how well durvalumab is working for people with cancer of the food pipe (oesophagus).
It is for people with cancer of the food pipe that has spread elsewhere in the body. Or continued to grow despite treatment and can’t be removed with an operation. This is locally advanced or advanced cancer.
Recruitment start: 1 October 2018
Recruitment end: 22 September 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Simon Pacey
AstraZeneca
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge
Last reviewed: 23 Sept 2021
CRUK internal database number: 16301
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
